Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 349 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Long-term outcomes Clear all

Conditions: Covid19, ME/CFS, SARS COV2, Novel Coronavirus Infection, Neurocognitive Disorders, Cardiovascular Diseases
Interventions: Not listed
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 6,000 participants
Timeline: 2020 – 2025
U.S. locations: 8
States / cities: Los Angeles, California • San Francisco, California • New Haven, Connecticut + 5 more

Conditions: Chronic Low Back Pain
Interventions: Intracept Procedure; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 25 Years to 70 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Carmel, Indiana • Austin, Texas

Conditions: Congenital Diaphragmatic Hernia
Interventions: Fetoscopic Endoluminal Tracheal Occlusion (FETO) Procedure; Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Autism Spectrum Disorder
Interventions: J-EMT for Toddlers with Autism; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 24 Months to 36 Months
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 2
States / cities: Evanston, Illinois • Nashville, Tennessee

Conditions: Parkinson's Disease (PD)
Interventions: Not listed
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older
Enrollment: 427 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 27
States / cities: Birmingham, Alabama • Sun City, Arizona • Palo Alto, California + 24 more

Conditions: Gastroesophageal Reflux Disease (GERD)
Interventions: Transoral Incisionless Fundoplication; Device
Lead sponsor: EndoGastric Solutions; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Ocala, Florida • Salem, Kentucky

Conditions: Adolescent Idiopathic Scoliosis
Interventions: Long-term outcomes; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 30 Years to 99 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Preeclampsia Postpartum, Adverse Pregnancy Outcomes
Interventions: usual postpartum care, usual postpartum care + community health worker intervention; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 16 Years to 56 Years · Female only
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Birmingham, Alabama

Conditions: Prostate Cancer
Interventions: Not listed
Lead sponsor: Myriad Genetic Laboratories, Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2029
U.S. locations: 7
States / cities: Homewood, Alabama • Long Beach, California • Bradenton, Florida + 4 more

Conditions: Excessive Daytime Sleepiness, Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS)
Interventions: Armodafinil; Drug
Lead sponsor: Cephalon; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 247 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 43
States / cities: Birmingham, Alabama • Tuscaloosa, Alabama • Phoenix, Arizona + 37 more

Conditions: Refractory Status Epilepticus
Interventions: Perampanel; Drug
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Pulmonary Embolism, Venous Thromboembolism, Deep Vein Thrombosis
Interventions: Not listed
Lead sponsor: Volcano Corporation; Industry
Eligibility: 19 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 3
States / cities: Atlanta, Georgia • Raleigh, North Carolina • Knoxville, Tennessee

Conditions: Multisystem Inflammatory Syndrome in Children (MIS-C)
Interventions: Not listed
Lead sponsor: Carelon Research; Other
Eligibility: Up to 21 Years
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 32
States / cities: Tuscaloosa, Alabama • Phoenix, Arizona • Los Angeles, California + 29 more

Conditions: Aortic Valve Disease
Interventions: Not listed
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 90 Years
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Plano, Texas

Conditions: Rhinoplasty
Interventions: Autologous Costal Cartilage Graft, Costal Cartilage Allograft.; Other
Lead sponsor: Musculoskeletal Transplant Foundation; Other
Eligibility: 18 Years to 60 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cardiac Surgery
Interventions: Aprotinin, Amicar; Drug
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years and older
Enrollment: 462 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Spinal Cord Injuries and Disorders (SCI/D)
Interventions: Caring Connections, Attention control; Other
Lead sponsor: Chicago Association for Research and Education in Science; Other
Eligibility: 18 Years to 90 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Hines, Illinois

Conditions: Primary Biliary Cholangitis (PBC)
Interventions: Elafibranor, Matched 80 mg placebo; Drug · Other
Lead sponsor: Ipsen; Industry
Eligibility: 18 Years and older
Enrollment: 276 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 43
States / cities: Tucson, Arizona • Little Rock, Arkansas • Coronado, California + 32 more

Conditions: Asthma
Interventions: Group A - Patient Education, Group B - Patient Education with Nutrition Counseling; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 323 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Diabetes, Diabetes Mellitus, Type 2
Interventions: semaglutide, placebo; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 50 Years and older
Enrollment: 3,297 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 97
States / cities: Birmingham, Alabama • Chandler, Arizona • Anaheim, California + 84 more

Conditions: NAFLD
Interventions: Not listed
Lead sponsor: Methodist Health System; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: HIV
Interventions: HIV D-/R+; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 19
States / cities: Phoenix, Arizona • Los Angeles, California • San Francisco, California + 14 more

Conditions: Cerebral Palsy, Femoral Derotation Osteotomy, Outcomes
Interventions: Motion Analysis, sterEOS Imaging of Lower Extremities, Surveys; Diagnostic Test · Behavioral
Lead sponsor: Gillette Children's Specialty Healthcare; Other
Eligibility: 25 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Lumbar Spinal Stenosis
Interventions: X STOP® Interspinous Process Decompression System; Device
Lead sponsor: Medtronic Spine LLC; Industry
Eligibility: 50 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 5
States / cities: San Francisco, California • Scarborough, Maine • Timonium, Maryland + 2 more

Search by objective public record fields.

Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

CLBP Single-Arm Long-Term Follow-up Study

Safety and Efficacy of Fetoscopic Endoluminal Tracheal Occlusion in Congenital Diaphragmatic Hernia

Communication Intervention for Toddlers With Autism

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study

Long-Term Outcome Following the Treatment of Pediatric Scoliosis

A Community Health Worker Intervention to Address Adverse Pregnancy Outcomes

Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing

Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus

Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System

Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children

Prospective Long-Term Outcomes of a Standardized Ross Procedure

Use of Allograft Cartilage in Cosmetic and Reconstructive Rhinoplasty

Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates

Caring Connections: A Program to Alleviate Social Isolation and Loneliness in Individuals Living With Spinal Cord Injury

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern

Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes

Short and Long Term Clinical and Patient-Reported Outcomes Associated With Intragastric Balloon Placement in Patients With Nonalcoholic Fatty Liver Disease

Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

Long-Term Outcomes of Femoral Derotation Osteotomy for Individuals With Cerebral Palsy

Long-Term Outcomes for Lumbar Spinal Stenosis Patients Treated With X STOP®